Previous studies demonstrated that CDK5 overexpression was implicated in the tumorigenesis and aggressiveness in several malignancies, for instance lung, pancreatic, neuroendocrine thyroid, and breast cancer [13, 12, 11, 10]. Here, CDK5 is linked to breast carcinoma.